CareNet (2150.T JPX) JPY 1124.00 pre-market Mar 2026: oversold bounce setup

We see 2150.T stock trading pre-market at JPY 1124.00 on 19 Mar 2026, signaling a possible short-term rebound after an oversold move. Volume is light at 51,100 shares versus an average of 196,687, which keeps price swings thin before the open. For traders, this setup suggests a measured oversold bounce approach, using tight risk controls and clear targets on the JPX in Japan.

2150.T stock pre-market snapshot

CareNet, Inc. (2150.T) is quoted at JPY 1124.00 in pre-market trade on the JPX on 19 Mar 2026, with an intra-session high of JPY 1125.00. Reported volume is 51,100 versus average volume 196,687, and the previous close was JPY 1124.00. This low relative volume and narrow intraday range reinforce a fragile, bounce-prone setup before regular hours.

Fundamentals driving 2150.T stock

CareNet shows EPS 32.60 and a market PE near 34.48, with book value per share JPY 259.34 and cash per share JPY 170.58. The company posts a net profit margin 12.72% and ROE 14.67%, while debt is negligible at debt to equity 0.01. These metrics support a stable valuation case, even as recent EPS growth slowed year-over-year.

Technical outlook for 2150.T stock — oversold bounce setup

Key technicals show a tight trading band with ATR 1.25 and Keltner channel mid JPY 1124.00, lower JPY 1121.50, upper JPY 1126.50, which points to low immediate volatility. The ADX reads 100.00, indicating a strong trend context; price sitting near the short-term low increases odds of a bounce trade. For an oversold bounce, watch for rising volume above avg 196,687 to confirm follow-through.

Meyka AI rating and price forecast for 2150.T stock

Meyka AI rates 2150.T with a score out of 100: 74.14 (B+) — BUY. This grade factors in S&P 500 and sector comparison, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a short-term target of JPY 1,280.00 and a 12-month target of JPY 1,450.00, implying near-term upside +13.86% and 12-month upside +28.94% versus JPY 1124.00. Forecasts are model-based projections and not guarantees.

Risks and sector context for 2150.T stock

CareNet operates in Healthcare information services, where sector YTD performance is +1.36% and average PE is 23.93, higher than CareNet’s current metrics. Key risks include slowing EPS growth, a recent net income decline of -24.54% year-over-year, and low free cash flow disclosure. A sector slowdown or weaker client demand could interrupt the bounce despite strong balance-sheet metrics.

Short-term trading strategy for 2150.T stock

For an oversold bounce, consider a staged entry near JPY 1120.00–1128.00 with a tight stop-loss at JPY 1,100.00 and an initial target at JPY 1,280.00. Use size limits because relative volume is 0.26x of average, which raises slippage risk. Confirm the trade with intraday volume above 70,000 and a break above JPY 1,140.00 for added conviction.

Final Thoughts

Key takeaways for 2150.T stock on 19 Mar 2026: CareNet trades at JPY 1124.00 in pre-market trade on the JPX, with low volume and a narrowly defined price band that favors an oversold bounce trade for nimble participants. Fundamental strength includes EPS 32.60, ROE 14.67%, and a solid cash buffer of JPY 170.58 per share, while EPS growth showed a recent decline. Meyka AI rates 2150.T 74.14 out of 100 (B+ – BUY) and recommends watching volume and a clean intraday break for confirmation. Meyka AI’s forecast model projects a short-term target of JPY 1,280.00 (+13.86%) and a 12-month target of JPY 1,450.00 (+28.94%) versus JPY 1124.00 today. Forecasts are model-based projections and not guarantees. Traders should pair the oversold-bounce plan with strict stops and monitor Healthcare sector moves and company updates at CareNet investor site and our coverage on the Meyka stock page Meyka stock page.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.